Literature DB >> 3931189

Progestin action and progesterone receptor structure in human breast cancer: a review.

K B Horwitz, L L Wei, S M Sedlacek, C N d'Arville.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1985        PMID： 3931189     DOI： 10.1016/b978-0-12-571141-8.50010-x

Source DB:  PubMed          Journal:  Recent Prog Horm Res        ISSN： 0079-9963


× No keyword cloud information.
  23 in total

Review 1.  Clinical pharmacokinetics of endocrine agents used in advanced breast cancer.

Authors:  P E Lønning; E A Lien; S Lundgren; S Kvinnsland
Journal:  Clin Pharmacokinet       Date:  1992-05       Impact factor: 6.447

2.  Multiple actions of synthetic 'progestins' on the growth of ZR-75-1 human breast cancer cells: an in vitro model for the simultaneous assay of androgen, progestin, estrogen, and glucocorticoid agonistic and antagonistic activities of steroids.

Authors:  R Poulin; D Baker; D Poirier; F Labrie
Journal:  Breast Cancer Res Treat       Date:  1991 Jan-Feb       Impact factor: 4.872

3.  Cloning of the chicken progesterone receptor.

Authors:  J M Jeltsch; Z Krozowski; C Quirin-Stricker; H Gronemeyer; R J Simpson; J M Garnier; A Krust; F Jacob; P Chambon
Journal:  Proc Natl Acad Sci U S A       Date:  1986-08       Impact factor: 11.205

4.  Comparative effect of embryonic mouse fibroblasts (Balb/c-3T3) on the proliferation of hormone-dependent (T-47D) and hormone-independent (MDA-MB-231) human breast cancer cell lines.

Authors:  G Chetrite; L Delalonde; J R Pasqualini
Journal:  Breast Cancer Res Treat       Date:  1993       Impact factor: 4.872

5.  Effects of antiprogestins on the rate of proliferation of breast cancer cells.

Authors:  K Iwasaki; B Underwood; M Herman; S Dinda; S Kodali; H J Kloosterboer; C Hurd; V K Moudgil
Journal:  Mol Cell Biochem       Date:  1999-08       Impact factor: 3.396

Review 6.  Tamoxifen resistance in breast cancer: elucidating mechanisms.

Authors:  L C Dorssers; S Van der Flier; A Brinkman; T van Agthoven; J Veldscholte; E M Berns; J G Klijn; L V Beex; J A Foekens
Journal:  Drugs       Date:  2001       Impact factor: 9.546

Review 7.  Expression profiling of human breast cancers and gene regulation by progesterone receptors.

Authors:  Britta M Jacobsen; Jennifer K Richer; Carol A Sartorius; Kathryn B Horwitz
Journal:  J Mammary Gland Biol Neoplasia       Date:  2003-07       Impact factor: 2.673

8.  Difference between R5020 and the antiprogestin RU486 in antiproliferative effects on human breast cancer cells.

Authors:  P G Gill; F Vignon; S Bardon; D Derocq; H Rochefort
Journal:  Breast Cancer Res Treat       Date:  1987-10       Impact factor: 4.872

9.  Antiestrogen binding sites in microsomal fractions of malignant and nonmalignant human breast tissues.

Authors:  R R Mehta; T K DasGupta
Journal:  Breast Cancer Res Treat       Date:  1987       Impact factor: 4.872

10.  Progesterone receptor distribution in the human endometrium. Analysis using monoclonal antibodies to the human progesterone receptor.

Authors:  M F Press; J A Udove; G L Greene
Journal:  Am J Pathol       Date:  1988-04       Impact factor: 4.307
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.